Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Librera OncoLink / Revisiones de Libros, Música y Videos
Reviewer: Ryan P. Smith. MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 1 de agosto del 2003
![]() |
Authors: Kristine Conner and Lauren Langford Publisher: O'Reilly ISBN: 0-596-50016-5 OncoLink Rating: |
Though much less common than other types of malignancies, ovarian cancer is the largest cause of death among gynecologic malignancies. The sole reason behind this is the relative difficulty in recognizing the subtle signs and symptoms of ovarian cancer and the subsequent propensity of it to spread prior to diagnosis. For this reason, education is the key in assisting women diagnosed with ovarian cancer. Ovarian Cancer: Your Guide to Taking Control is an exceptional resource in this area. Kristine Conner is a writer specializing in topics related to medicine and education, contributing many articles and education materials in accessible terms for patients. Lauren Dieguez Langford was a long-time, very active patient advocate for women with breast and ovarian cancer who became even more active in the ovarian cancer community after being diagnosed with ovarian cancer herself. She used her experiences to contribute much of the book prior to succumbing to her disease. Teamed together, with combined areas of expertise, they have compiled an extremely complete guide to every aspect of ovarian cancer.
Toward the beginning of the book, there is a chapter entitled "An Ovarian Cancer Primer", which serves as just that: an accurate and complete-but not overwhelming-description of all aspects of how ovarian cancer behaves. However, the book does not stop there. It goes on with detailed descriptions of not only medical procedures such as surgery and chemotherapy, but also other, equally important facets of being diagnosed with ovarian cancer, such as side effects, coping strategies, and resources for support groups. The authors obviously have more than a fair knowledge of ovarian cancer, as they devote an entire chapter to finding a gynecologic oncologist, which is perhaps the most important single step in being treated. In addition, there is a complete chapter on the aspects and function of clinical trials, usually a black box for most patients. The chapter introduces clinical trials, describes the types of trials, and gives detailed information regarding myths about trials, their pros and cons, and resources to determine if a patient would qualify for trials. There is even a chapter on dealing with employment and insurance issues, which most healthcare professionals are ignorant about or ignore altogether. The authors recognize that this is an important section to include, as it often affects patients' lives more than the majority of other aspects of the disease. Other chapters include information on follow-up standards, coping processes, and tastefully deals with end of life issues.
Ovarian Cancer: Your Guide to Taking Control is an exceptional book. It is complete in every aspect. It relays information in an easy to read fashion, but includes all information that should be communicated. It mixes in stories from actual patients with apropos stories that supplement the text. These are not simple anectdotes, but are well done and further elucidate the points the authors wish to convey. This will serve as a reminder to women reading the book that they are not alone in fighting this disease. We highly recommend Ovarian Cancer: Your Guide to Taking Control.
Dr. Vapiwala discusses the public awareness of prostate cancer and the public support for the disease. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

